Status | Study |
Not yet recruiting |
Study Name: Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer Condition: Grade 1 Endometrial Endometrioid Adenocarcinoma Grade 2 Endometrial Endometrioid Adenocarcin Date: 2017-01-11 Interventions: Drug: Entinostat Given PO |
Recruiting |
Study Name: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers Condition: Cervical Adenosarcoma Cervical Adenosquamous Carcinoma Date: 2013-12-19 Interventions: Biological: Bevacizumab Given |
Completed |
Study Name: Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors Condition: Tumor Date: 2006-12-18 Interventions: Drug: belinostat 300, 600, or |
Completed |
Study Name: Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma Condition: Solid Tumor Lymphoma Date: 2006-12-18 Interventions: Drug: oral belinostat oral belinostat dosed once or twice daily at continuous and discontinuous dosing s |